Cell-SELEX-based selection of aptamers that recognize distinct targets on metastatic colorectal cancer cells
- 1 August 2014
- journal article
- Published by Elsevier in Biomaterials
- Vol. 35 (25) , 6998-7007
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China (20875103, 21375149)
- National Basic Research Program of China (2011CB935800)
This publication has 35 references indexed in Scilit:
- PEI protected aptamer molecular probes for contrast-enhanced in vivo cancer imagingBiomaterials, 2012
- Aptamer-conjugated and drug-loaded acoustic droplets for ultrasound theranosisBiomaterials, 2012
- Aptamers as therapeuticsNature Reviews Drug Discovery, 2010
- The future of aptamers in medicineJournal of Clinical Pathology, 2010
- Aptamers Generated from Cell-SELEX for Molecular Medicine: A Chemical Biology ApproachAccounts of Chemical Research, 2009
- Aptamer-Facilitated Biomarker Discovery (AptaBiD)Journal of the American Chemical Society, 2008
- Biology of colorectal liver metastases: A reviewJournal of Surgical Oncology, 2006
- Surgical Resection of Hepatic and Pulmonary Metastases from Colorectal CarcinomaJournal of the American College of Surgeons, 2006
- In vitro selection of RNA molecules that bind specific ligandsNature, 1990
- Systematic Evolution of Ligands by Exponential Enrichment: RNA Ligands to Bacteriophage T4 DNA PolymeraseScience, 1990